4//SEC Filing
RAY RUSSELL T 4
Accession 0001213900-22-002425
CIK 0001690080other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:33 PM ET
Size
4.9 KB
Accession
0001213900-22-002425
Insider Transaction Report
Form 4
RAY RUSSELL T
Director
Transactions
- Award
Common Stock
2022-01-14$3.04/sh+4,728$14,373→ 4,728 total
Footnotes (1)
- [F1]Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001225960
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:33 PM ET
- Size
- 4.9 KB